ABT - Abbott Laboratories

NYSE - Nasdaq Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts19192424
Avg. Estimate1.051.114.44.62
Low estimate1.011.094.354.5
High estimate1.11.154.454.93
Year ago EPS1.431.155.344.4
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts16162424
Avg. Estimate9.7B9.78B39.63B41.4B
Low estimate9.52B9.65B39B40.72B
High estimate9.96B10.01B41.03B43.52B
Year ago sales11.26B9.68B43.65B39.63B
Sales growth (year/est)-13.80%1.10%-9.20%4.50%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS1.130.940.920.99
Actual EPS1.431.151.031.03
Difference0.30.210.110.04
Surprise %26.50%22.30%12.00%4.00%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate1.051.114.44.62
7 days ago1.051.114.44.62
30 days ago1.051.114.44.61
60 days ago1.081.124.44.82
90 days ago1.081.114.44.85
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesABTIndustrySector(s)S&P 500
Current qtr.-26.60%N/AN/AN/A
Next qtr.-3.50%N/AN/AN/A
Current year-17.60%N/AN/AN/A
Next year5.00%N/AN/AN/A
Next 5 years (per annum)-2.70%N/AN/AN/A
Past 5 years (per annum)15.73%N/AN/AN/A